237 - Poster Session A
Clinicopathologic benchmark for prognostic modeling of advanced epithelial ovarian cancer long-term survival: a Gynecologic Oncology Group (GOG) analysis
Saturday, March 22, 2014: 6:05 PM
West Exhibit Hall (Tampa Convention Center)
Y. Casablanca1, A. Miller2, N. S. Horowitz3, B. J. Rungruang4, T. C. Krivak5, S. D. Richard6, N. Rodriguez7, M. A. Bookman8, G. L. Maxwell9 and C. A. Hamilton1
1Walter Reed National Military Medical Center, Bethesda, MD, 2Gynecologic Oncology Group, Buffalo, NY, 3Harvard University, Boston, MA, 4Georgia Reagents University, Evans, GA, 5Western Pennsylvania Hospital, Pittsburgh, PA, 6Hahnemann University Hospital/Drexel University College of Medicine, Philadelphia, PA, 7Loma Linda University Medical Center, Loma Linda, CA, 8University of Arizona Cancer Center, Tucson, AZ, 9Inova Fairfax Hospital, Falls Church, VA
